跳至主要内容
临床试验/NCT00954018
NCT00954018已完成不适用

Respiratory Microbial Community Composition and Metabolism in Cystic Fibrosis

Boston Children's Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1

研究概览

简要总结

Scientist have begun to realize that many types of bacteria often live together as a complex community, and the investigators wish to apply that idea to the bacteria in the respiratory system of people with Cystic Fibrosis (CF). It is possible that the survival of the many millions of bacteria in the CF lung depends on the production of special chemicals that might be made only by very few types of bacteria. If that is true, medicines that interfere with those chemicals could treat the lung infections that cause trouble for nearly all people with CF. The investigators wish to study the production of several potentially critical chemicals by the respiratory bacteria and to examine the effect of those chemicals on the makeup of the entire community of bacteria. To detect all the bacteria in that community, the investigators will use new methods that use bacterial genetic information and can detect hundreds of different types of bacteria in respiratory samples of individual CF patients.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
2 Years 至 55 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • confirmed diagnosis of Cystic Fibrosis
  • 2 to 55 years of age

排除标准

  • 未提供

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Martin

Assistant Professor of Pediatrics

Boston Children's Hospital

研究点 (1)

Loading locations...

相似试验

Microbial Community Composition and Metabolism in... | 临床试验